Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 14,920 | 6,400 |
| Marketable Securities | 50 | 50 |
| Other current assets | 160 | 50 |
| TOTAL | $15,130 | $6,500 |
| Non-Current Assets | ||
| Other Non-Current Assets | 110 | 90 |
| TOTAL | $110 | $90 |
| Total Assets | $16,270 | $7,310 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 540 | 170 |
| Accrued Expenses | 400 | 110 |
| Other current liabilities | 100 | 40 |
| TOTAL | $1,060 | $340 |
| Non-Current Liabilities | ||
| TOTAL | $30 | $30 |
| Total Liabilities | $1,100 | $370 |
| Shareholders' Equity | ||
| Common Shares | 10 | 7 |
| Retained earnings | -9,580 | -1,920 |
| Other shareholders' equity | -10 | -7 |
| TOTAL | $15,170 | $6,930 |
| Total Liabilities And Equity | $16,270 | $7,300 |